Gyre Therapeutics GYRE
NASDAQ GYRE
$5.90 -0.27 (-4.38%)
At close: Oct 21, 2026 · 4:00 PM EDT

Gyre Therapeutics (GYRE) Share-based Compensation (IS) (2011 - 2012)

Updated

Gyre Therapeutics' Share-based Compensation (IS) came in at $1.44 million for Q3 2012, down 33.0% from $2.15 million a year earlier and down 53.7% from the prior quarter.

Analysis

Gyre Therapeutics (GYRE) Share-based Compensation (IS) (2011 - 2012) Analysis & Trends

Over the trailing twelve months to Sep 30, 2012, Gyre Therapeutics reported Share-based Compensation (IS) of $8.9 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Gyre Therapeutics 592.25 Mn 360.40 Mn 26.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 1.44 Mn
Jun 30, 2012 3.11 Mn
Sep 30, 2011 2.15 Mn
Jun 30, 2011 2.20 Mn
API Access

Gyre Therapeutics Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=GYRE&period=max&api_key=YOUR_API_KEY